The early diagnosis and treatment of neuromyelitis optica (NMO) generally improve the outlook for people with this condition. Corticosteroids and immunotherapy are the main treatment options. NMO, ...

SAN DIEGO — Treatment with daratumumab, a monoclonal antibody approved to treat multiple myeloma, was associated with a significant decrease in relapse risk in patients with aquaporin-4 immunoglobulin ...

The drug eculizumab, a synthetic antibody that inhibits the inflammatory response, significantly reduced the risk of relapse with neuromyelitis optica spectrum disorder (NMOSD). This rare but severe ...

Neuromyelitis optica spectrum disorder (NMOSD) is an autoimmune disorder that mostly affects your eyes and spinal cord. Your immune system attacks a specific protein, called aquaporin-4 (AQP4). The ...

Neuromyelitis optica, or NMO, is a rare disease that mostly affects your eyes and spinal cord. It’s also known as Devic's disease. NMO happens when your body’s immune system attacks healthy cells in ...

Please provide your email address to receive an email when new articles are posted on . Ultomiris is a C5 complement inhibitor for neuromyelitis optica spectrum disorder. Trial patients did not ...

Conference MDAngle offers personal perspectives from conference attendees, showcasing their anticipation, quick takeaways, and insights into how the presented research will affect their patients. Dr ...

Neuromyelitis optica spectrum disorder (NMOSD) is a relapsing, autoimmune, inflammatory disorder that typically affects the optic nerves and spinal cord. At least two thirds of cases are associated ...

In patients with NMOSD, there is a decline in executive function in terms of sustained attention, phonological verbal fluency, and working memory. Neuropsychological assessments in the clinical ...

In the autoimmune disorder neuromyelitis optica (NMO), the immune system attacks the optic nerves and spinal cord. This can cause symptoms such as loss of vision and changes in sensation. Early and ...

The combination of optic neuritis and myelitis, the so-called Neuromyelitis optica is an uncommon pattern of demyelinating disorder. In 1870, Sir Thomas Clifford Allbutt first reported the association ...